Thrivent Financial for Lutherans Increases Encompass Health Co. Stock Holdings (NYSE:EHC)

Thrivent Financial for Lutherans increased its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 2,302.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 603,558 shares of the company’s stock after purchasing an additional 578,438 shares during the quarter. Thrivent Financial for Lutherans owned about 0.60% of Encompass Health worth $51,780,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC boosted its holdings in Encompass Health by 1.3% in the second quarter. Commonwealth Equity Services LLC now owns 9,845 shares of the company’s stock worth $845,000 after buying an additional 123 shares during the last quarter. Legacy Wealth Asset Management LLC boosted its holdings in Encompass Health by 1.5% in the first quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock worth $712,000 after buying an additional 130 shares in the last quarter. Smith Group Asset Management LLC boosted its holdings in Encompass Health by 1.2% in the first quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock worth $997,000 after buying an additional 140 shares during the last quarter. Horrell Capital Management Inc. boosted its holdings in Encompass Health by 0.5% in the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after buying an additional 147 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Encompass Health by 31.9% in the first quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after acquiring an additional 149 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s shares.

The Wall Street analyst weighs in

EHC has been the subject of a number of research reports. Stephens reiterated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a report on Tuesday, August 6th. Truist Financial upped their target price on Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a report on Thursday, August 15th. UBS Group boosted their price target on Encompass Health from $96.00 to $100.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Leerink Partners initiated coverage on Encompass Health in a report on Wednesday, July 10th. They set an “outperform” rating and a $100.00 price target for the company. Finally, Leerink Partners upgraded Encompass Health to a “buy-buy” rating in a report on Wednesday, July 10th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $100.38, based on data from MarketBeat.com.

Check out our latest review of Encompass Health

Incorporates health pricing performance

NYSE EHC opened at $92.65 on Monday. Encompass Health Co. has a one year low of $57.55 and a one year high of $94.59. The stock has a 50-day moving average of $90.04 and a 200-day moving average of $85.32. The company has a market cap of $9.33 billion, a price-to-earnings ratio of 25.04, a PEG ratio of 1.39 and a beta of 0.88. The company has a debt-to-equity ratio of 1.08, a quick ratio of 1.35, and a current ratio of 1.35.

Encompass Health (NYSE:EHC – Get Free Report ) last issued its quarterly earnings data on Monday, August 5th. The company reported $1.11 EPS for the quarter, topping the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 17.83% and a net margin of 7.88%. The company had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.30 billion. During the same period last year, the company earned $0.95 EPS. Encompass Health’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, sell-side analysts estimate that Encompass Health Co. will post 4.18 EPS for the current year.

Embed health increases dividends

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a $0.17 dividend. This represents an annualized dividend of $0.68 and a yield of 0.73%. This is a boost from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. Encompass Health’s dividend payout ratio (DPR) is currently 18.38%.

Encompass Health declared that its Board of Directors has initiated a stock buyback program on Wednesday, July 24th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 5.4% of its shares through open market purchases. Stock buyback programs are usually a sign that a company’s board of directors believes its stock is undervalued.

Insiders place their bets

In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of the business’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total value of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares of the company’s stock, valued at $11,761,839.18. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available on the SEC’s website. Insiders own 2.10% of the company’s shares.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation provides post-acute care services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy and ancillary services. The Company provides specialized inpatient rehabilitation treatment to patients who have suffered physical or cognitive disabilities or injuries due to medical conditions such as strokes, hip fractures and various debilitating neurological conditions.

Read more

Get news and reviews for Encompass Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Encompass Health and related companies with MarketBeat.com’s FREE daily email newsletter.